Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Julia Hippisley-Cox


Professor of Clinical Epidemiology and General Practice

  • Professor of Clinical Epidemiology & General Practice
  • Professorial Fellow St Anne's College
  • Honorary consultant NHS England
  • Honorary consultant Oxford Health NHS Foundation Trust
  • General Practitioner, Woodstock Surgery, Oxfordshire CCG
  • Founder and Director of QResearch
  • Founder and Director of QSurveillance (real time infectious diseases surveillance system)
  • Founder, Shareholder and Former director of ClinRisk Ltd
  • Trustee of the EMIS National User Group.
  • Member Steering Group Centre for Personalised Medicine, St Anne's College
  • Member NIHR Research for Patient Benefit Panel
  • Chair COVID Risk Stratification SubGroup of NERVTAG
  • Member COVID Risk Stratification Implementation Board
  • Member SAGE 40 group for consideration of the occupational mitigations for BAME people during the COVID 19 crisis
  • The National Expert Group to create protocol and clinical policy for use of neutralising monoclonal antibodies (nMABs) across the UK
  • Therapeutics Clinical Review Panel – Modelling group (from March 2022)
  • Oxford Cancer Oversight Committee

Julia qualified with distinction from Sheffield University Medical School in 1989 where she was awarded the Prize in Medicine, Surgery, General Practice and Obstetrics and Gynaecology. In 1995 she was awarded a distinction in the MRCGP examination and awarded FRCGP in 2005. She became a Member of the Royal College of Physicians in 1994, and a Fellow in 2013. She was appointed as Lecturer at the University of Nottingham in 1995, Senior Lecturer in 1999, Reader in 2004. She was promoted to Professor of Clinical Epidemiology & General Practice in 2005 where she stayed until her appointment at the University of Oxford.

In 2009 she was  awarded the John Fry Award by the Royal College of General Practitioners. She was awarded RCGP paper of the year for the best paper published in the cancer category (2012) and cardiovascular category (2018). In 2013 she was awarded the Dr John Perry Prize for an outstanding contribution to NHS IT for her work developing the widely used too. In 2021 she was awarded the Dr John Perry prize for the QCovid risk stratification tool.

Julia's research interests are very broad and include large scale clinical epidemiology, drug safety and the development of risk prediction algorithms using electronic databases from general practices. She is the co-founder of the QResearch database ( which is one of the largest clinical research databases worldwide. By 2022, it has doubled in size to to cover over 1500 GP practices, representing approximately 25% of the UK population. The database is also linked to hospital, mortality & cancer data, COVID test results, COVID-19 vaccination and ICNARC ICU data. She has developed and validated risk prediction algorithms for a range of diseases including cardiovascular disease, cancer fracture, diabetes and other conditions. These tools are now widely used across the NHS.

Declarations of interests

For declarations of interest please see here

Key publications

Recent publications